Related references
Note: Only part of the references are listed.Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti et al.
CELLULAR IMMUNOLOGY (2019)
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer
Emmett V. Schmidt
SEMINARS IN IMMUNOPATHOLOGY (2019)
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
Anu Sharma et al.
CLINICAL CANCER RESEARCH (2019)
Implications of the tumor immune microenvironment for staging and therapeutics
Janis M. Taube et al.
MODERN PATHOLOGY (2018)
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Robert D. Morgan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Xuexiang Du et al.
CELL RESEARCH (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
Pierpaola Davalli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
PARP Inhibitors in Ovarian Cancer
Gloria Mittica et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
Michael Rueckert et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Toxicity of radiation and immunotherapy combinations
Vivek Verma et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Role of the immunosuppressive microenvironment in immunotherapy
Garth W. Tormoen et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
The DNA damage response in immunotherapy and radiation
Robert M. Samstein et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation
Eric C. Ko et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Radiation effects on antitumor immune responses: current perspectives and challenges
Thomas Walle et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Radiotherapy and checkpoint inhibitors: a winning new combination?
Eric C. Ko et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
Abul Azad et al.
EMBO MOLECULAR MEDICINE (2017)
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Benjamin Herzberg et al.
ONCOLOGIST (2017)
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Laetitia Nebot-Bral et al.
EUROPEAN JOURNAL OF CANCER (2017)
Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases
Benjamin Frey et al.
IMMUNOLOGICAL REVIEWS (2017)
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study
Jung-Min Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer
Xiaomei Gong et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Poly(ADP-ribose) polymerase activity and inhibition in cancer
Caleb Dulaney et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
Paul Lesueur et al.
ONCOTARGET (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports
Daniel K. Ebner et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)
Willy Hugo et al.
CELL (2017)
The Immune System in Cancer Prevention, Development and Therapy
Serge M. Candeias et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Microsatellite Instability as a Biomarker for PD-1 Blockade
Jonathan C. Dudley et al.
CLINICAL CANCER RESEARCH (2016)
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing
Sofia R. Gameiro et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer
Aaron T. Wild et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment
Anselmo Papa et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype
Marie Kostine et al.
MODERN PATHOLOGY (2016)
The current status of PARP inhibitors in ovarian cancer
Jennifer McLachlan et al.
TUMORI JOURNAL (2016)
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Anja Derer et al.
FRONTIERS IN IMMUNOLOGY (2016)
Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
Benjamin Lemasson et al.
NEOPLASIA (2016)
The current status of PARP inhibitors in ovarian cancer
Jennifer McLachlan et al.
TUMORI JOURNAL (2016)
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
L. Paoluzzi et al.
CLINICAL SARCOMA RESEARCH (2016)
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1-/- murine model of ovarian cancer
Jing Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Clare L. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
Andrew B. Sharabi et al.
LANCET ONCOLOGY (2015)
Tumor-infiltrating lymphocytes for the treatment of metastatic cancer
M. H. Geukes Foppen et al.
MOLECULAR ONCOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
Claire Vanpouille-Box et al.
VACCINE (2015)
CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer
Tomoe Higuchi et al.
CANCER IMMUNOLOGY RESEARCH (2015)
PD-1 Restrains Radiotherapy-Induced Abscopal Effect
Sean S. Park et al.
CANCER IMMUNOLOGY RESEARCH (2015)
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
M. Li et al.
ONCOGENE (2015)
Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFNγ-Dependent Cell-Cycle Arrest
Hirokazu Matsushita et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
Andrew B. Sharabi et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi et al.
CANCER RESEARCH (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway
Kyu-Shik Lee et al.
MOLECULAR MEDICINE REPORTS (2014)
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888
Richard Tuli et al.
TRANSLATIONAL ONCOLOGY (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
Antonio M. Grimaldi et al.
ONCOIMMUNOLOGY (2014)
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line
Jennifer J. Parker et al.
CLINICAL IMMUNOLOGY (2013)
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
Helen Angel et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
A role of intracellular mono-ADP-ribosylation in cancer biology
Emanuele S. Scarpa et al.
FEBS JOURNAL (2013)
Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic γδ T Lymphocytes to Tumor Beds
Telma Lanca et al.
JOURNAL OF IMMUNOLOGY (2013)
Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage
Hae-June Lee et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Immunologically augmented cancer treatment using modern radiotherapy
Marco Durante et al.
TRENDS IN MOLECULAR MEDICINE (2013)
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Encouse B. Golden et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Anurag Gupta et al.
JOURNAL OF IMMUNOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cytokines in Radiobiological Responses: A Review
Doerthe Schaue et al.
RADIATION RESEARCH (2012)
Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Federica Laudisi et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
RADIATION ENHANCES REGULATORY T CELL REPRESENTATION
Evelyn L. Kachikwu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer
William Y. Song et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies
Wael Y. Mansour et al.
NUCLEIC ACIDS RESEARCH (2010)
Up-regulation of the Pro-inflammatory Chemokine CXCL16 is a Common Response of Tumor Cells to Ionizing Radiation
Satoko Matsumura et al.
RADIATION RESEARCH (2010)
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma
M. Enderlin et al.
CANCER GENE THERAPY (2009)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
COMPARISON OF BIOLOGICAL EFFECTIVENESS OF CARBON-ION BEAMS IN JAPAN AND GERMANY
Akiko Uzavva et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
APPLICATION OF CARBON-ION BEAMS OR GAMMA-RAYS ON PRIMARY TUMORS DOES NOT CHANGE THE EXPRESSION PROFILES OF METASTATIC TUMORS IN AN IN VIVO MURINE MODEL
Tomoaki Tamaki et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity
Amit A. Lugade et al.
JOURNAL OF IMMUNOLOGY (2008)
Regulation of NFAT by poly (ADP-ribose) polymerase activity in T cells
Rut Valdor et al.
MOLECULAR IMMUNOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
A key role for poly(ADP-Ribose) polymerase-1 activity during human dendritic cell maturation
Alessandra Aldinucci et al.
JOURNAL OF IMMUNOLOGY (2007)
Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice
M. Haddad et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes
Fredrik B. Thoren et al.
JOURNAL OF IMMUNOLOGY (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells
A Ludwig et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
CTLA-4: new insights into its biological function and use in tumor immunotherapy
JG Egen et al.
NATURE IMMUNOLOGY (2002)
Proton RBE for early intestinal tolerance in mice after fractionated irradiation
J Gueulette et al.
RADIOTHERAPY AND ONCOLOGY (2001)
The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ
TJ Paradis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Inhibition of poly( ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
HB Jijon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Share Paper
